Anekwe Onwuanyi to Treatment Outcome
This is a "connection" page, showing publications Anekwe Onwuanyi has written about Treatment Outcome.
Connection Strength
0.276
-
Egbuche O, Ekechukwu I, Effoe V, Maduabum N, Millard HR, Maihemuti A, Cross JA, Adedinsewo D, Onwuanyi AE. Effect of ?-blocker Therapy on Hospital Readmission and Mortality in Heart Failure Patients With Concurrent Cocaine Use. J Cardiovasc Pharmacol Ther. 2018 11; 23(6):518-523.
Score: 0.122
-
Adedinsewo D, Xu J, Agasthi P, Oderinde A, Adekeye O, Sachdeva R, Rust G, Onwuanyi A. Effect of Digoxin Use Among Medicaid Enrollees With Atrial Fibrillation. Circ Arrhythm Electrophysiol. 2017 May; 10(5):e004573.
Score: 0.113
-
Mentz RJ, Bittner V, Schulte PJ, Fleg JL, Pi?a IL, Keteyian SJ, Moe G, Nigam A, Swank AM, Onwuanyi AE, Fitz-Gerald M, Kao A, Ellis SJ, Kraus WE, Whellan DJ, O'Connor CM. Race, exercise training, and outcomes in chronic heart failure: findings from Heart Failure - a Controlled Trial Investigating Outcomes in Exercise TraiNing (HF-ACTION). Am Heart J. 2013 Sep; 166(3):488-95.
Score: 0.022
-
Whellan DJ, Nigam A, Arnold M, Starr AZ, Hill J, Fletcher G, Ellis SJ, Cooper L, Onwuanyi A, Chandler B, Keteyian SJ, Ewald G, Kao A, Gheorghiade M. Benefit of exercise therapy for systolic heart failure in relation to disease severity and etiology-findings from the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training study. Am Heart J. 2011 Dec; 162(6):1003-10.
Score: 0.019